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Desmosterolosis is an autosomal recessive disorder of cholesterol biosynthesis caused by biallelic mutations of
DHCR24 (homozygous or compound heterozygous), which encodes 3-β-hydroxysterol Δ-24-reductase. We report
two sisters homozygous for the 571G>A (E191K) DHCR24 mutation. Comparison of the propositae to other reported
individuals shows that psychomotor developmental delay, failure to thrive, dysgenesis of the corpus callosum,
cerebral white matter atrophy and spasticity likely constitute the minimal desmosterolosis phenotype. The
nonspecific features of desmosterolosis make it difficult to suspect clinically and therefore screening for it should be
entertained early in the diagnostic evaluation.
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Background
Desmosterolosis is an infrequently reported disorder of
cholesterol biosynthesis causing syndromic intellectual
disability (ID) arising from biallelic mutations (homozy-
gous or compound heterozygous) in DHCR24. DHCR24
encodes 3-β-hydroxysterol Δ-24-reductase (DHCR24)
[1,2], which catalyzes the C-24 NADPH-dependent re-
duction of the 24–25 double bond of cholesterol precur-
sors [3,4].
Case report
We present two sisters with syndromic ID and desmos-
terolosis. Following uncomplicated pregnancies, they
were born at term with normal growth parameters. Each
had transient neonatal seizures. Their family history was
noncontributory.
Beginning in infancy, they manifested growth restric-
tion and delayed milestones for speech, fine and gross
motor, and adaptive development. Patient 1 was able to* Correspondence: nboerkoel@cfri.ca
†Equal contributors
1Department of Medical Genetics, University of British Columbia, 4500 Oak
St., Vancouver, British Columbia, V6H 3N1, Canada
2Child and Family Research Institute, Children’s and Women’s Health Centre
of British Columbia, 950 West 28th Ave., Vancouver, British Columbia, V5Z
4H4, Canada
Full list of author information is available at the end of the article
© 2014 Dias et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.walk with support and communicate with short phrases
by 6 years; Patient 2 developed these skills by 8 years.
Patient 1 had an IQ of 42 at 10.5 years. Patient 2 had an
IQ of 46 at 5.5 years. Neither lost skills although Patient
1 had progressive sensorineural hearing loss.
On examination at 13.8 and 9.1 years, respectively,
each had similar dysmorphic features. Patient 1 had
short stature (<1st centile) with proportionate limbs, a
weight of 41 kg (13th centile), and a head circumference
of 55.2 cm (86th centile). Patient 2 had a height of
117.8 cm (1st centile), a weight of 21.3 kg (3rd centile),
and a head circumference of 49.5 cm (4th centile). They
had mild generalized hirsutism, facial dysmorphism, high
arched hard palates, optic atrophy, nystagmus, spasticity,
deep tendon hyperreflexia, camptodactyly of the fingers
and toes, and muscle wasting, particularly of the thenar
and hypothenar muscles (Figure 1A, B, C, F, G and H).
Patient 1 also had a midline cleft of the soft palate as
well as a short neck and large ears (>97th centile). Pa-
tient 2 also had myopia.Investigations
Each had extensive non-diagnostic laboratory testing.
This included normal profiles for urine organic acids,
urine purines and pyrimidines, plasma amino acids, and
plasma very long chain fatty acids as well as urine. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Clinical and MRI features of siblings with Desmosterolosis. A to C: Patient 1 craniofacial and hand features at age 14.8 years. Her
dysmorphic features show scaphocephaly, tall forehead with bitemporal narrowing, short palpebral fissures, long nose, hypoplastic nasal alae,
prominent columella, and low-set posteriorly rotated ears. D, E (Axial T1, Sagittal FLAIR): Patient 1 brain MRI showing white matter volume loss,
dilated ventricles, thin corpus callosum, and peg-like cerebellar tonsils displaced into the upper cervical canal through the foramen magnum
(Chiari I malformation). F to H: Patient 2 craniofacial and hand features at age 10.1 years, similar to Patient 1. I, J (Axial T1 and Sagittal FLAIR):
Patient 2 brain MRI showing prominent and irregular ventricles, thin corpus callosum, and Chiari I malformation.
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function studies, transferrin isoelectric focusing and levels
for lactate, ammonia, uric acid, albumin, creatinine phos-
phokinase, and thyroid stimulating hormone. Each had a
normal karyotype and no evidence of a genomic deletion
or duplication detectable by array comparative genomic
hybridization. Patient 1 also had normal nucleotide exci-
sion repair assays, electromyography and nerve conduc-
tion studies. Patient 2 had normal complete blood counts
and levels for copper, ceruloplasmin and blood acylcarni-
tines; her EEG identified no focal seizure activity. The
patients were unavailable for additional testing, specif-
ically plasma sterols, which were not performed on
initial assessment.
Radiological assessment showed that both had dislo-
cated radial heads and bilateral equinovarus. In addition,
Patient 1 had a small and deformed pelvis, lumbar scoli-
osis, and moderate osteopenia. Patient 2 had parietal
foramina.
Magnetic resonance imaging (MRI) identified mild brain
atrophy, asymmetric ventriculomegaly, a thin corpus cal-
losum, and a Chiari I malformation (Figure 1D, E, I and J)
In addition, Patient 1 had a sacral cyst suggestive of a
meningocele or dural/perineural cyst.Exome sequencing and biochemical confirmation of
desmosterolosis
Exome sequencing (for methods see Additional file 1) [5]
identified a homozygous DHCR24 mutation (NM_014762.3:
c.571G>A; p.E191K), a recognized cause of desmosterolosis
(Additional file 1, Supplementary methods and Additional
file 2: Figure S1A) [2]. Sanger sequencing confirmed this
and the carrier state of the parents (Additional file 2:
Figure S1B). As predicted, gas chromatography-mass
spectroscopy analysis of lysates from cultured lympho-
blastoid cells [6] from the propositae detected an in-
creased ratio of desmosterol to total sterols (Figure 2). All
other sterols measured (Supplementary methods) includ-
ing cholesterol and 7-dehydrocholesterol were within nor-
mal range compared to healthy controls.Conclusions
We present two sisters with the biallelic mutation
NM_014762.3:c.571G>A in DHCR24. The recurrence of
this mutation [2] in a different ethnic group implies that
this mutation arose independently and suggests that mu-
tations altering only certain amino acids give rise to a vi-


















Figure 2 Biochemical confirmation of desmosterolosis. Comparative sterol profiles for the patients (second and third bar sets), heterozygous
parents (fourth and fifth bar sets), and unaffected control (first bar set). Sterols were measured in lysates from lymphoblasts cultured in
delipidated medium for 3 days and showed a 17–25 fold increased ratio of desmosterol to total sterols in comparison to controls,
whereas as heterozygous parents present a 1.7 and 1.5 increase, respectively. Each bar represents the average of 3 technical replicates.
7-DHC is represented as an internal control.
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sitae were discordant for microretrognathia, cleft palate,
large joint contractures, deafness, and skull foramina
(Table 1). In contrast, the previously reported four cousins
of a consanguineous family were discordant for oculo-
motor abnormalities and seizures (Patients 4–7, Table 1).
This might suggest either that the genetic backgrounds of
the propositae are significantly different or that because of
their consanguinity, the four family members reported by
Zolotushko et al. [7] share other genomic or epigenetic
variants modifying the expressivity of desmosterolosis.
Comparison of the propositae to Patient 3 (Table 1),
who has the same DHCR24 mutation, provides an as-
sessment of interfamilial genotype-phenotype concord-
ance [2]. They were discordant for dysmorphic facial
features, oculomotor abnormalities, seizures, brain ventri-
culomegaly, cutis aplasia, limb anomalies, and congenital
heart defects. They were concordant for ID, failure to
thrive, short stature, spasticity, distal arthrogryposis, dys-
genesis of the corpus callosum, and cerebral white matter
atrophy. Comparison of the propositae to all reported in
individuals with desmosterolosis (Table 1) [1,2,7-9] identi-
fies ID, failure to thrive, spasticity, dysgenesis of the cor-
pus callosum, and cerebral white matter atrophy as the
minimal clinical phenotype for desmosterolosis. Distal
arthrogryposis occurred in 8 of 9 individuals (Table 1).
This minimal phenotype, which is not distinctive and the
absence of sterol testing, explains the decade-long diag-
nostic odyssey of the propositae.Review of all reported patients suggests a minimal
genotype-phenotype correlation for desmosterolosis.
Only individuals with mutations affecting the 3-β-
hydroxysterol Δ-24-reductase cytoplasmic domain had
rhizomelia (Patients 8 and 9, Table 1). Sharing this feature
with the knockout mice [10], might suggest that muta-
tions in the cytoplasmic domain disrupt enzyme function
more severely than mutations in the FAD-binding domain
(protein features of UniProt Q15392 [11]).
The neurological features of desmosterolosis might
arise from either deficiency of cholesterol biosynthesis
or the toxic effects of sterols accumulating upstream of
3-β-hydroxysterol Δ-24-reductase. Both mechanisms
contribute to other disorders of cholesterol biosynthesis
and thus likely apply here [12]. The non-progressive neuro-
pathology in desmosterolosis is in keeping with the pri-
mary impact occurring during brain development.
In summary, the pleiotropy and nonspecificity of des-
mosterolosis explain the long diagnostic odyssey of the
propositae. Also, findings of developmental delay, CNS
malformation, spasticity (with or without distal arthro-
gryposis), short stature with and without limb anomalies
are sufficient indication to screen for disorders of chol-
esterol biosynthesis.
Patient consent and ethics approval
Individuals enrolled in the study gave informed consent
for protocol H07-02142 (Vancouver, BC, Canada), ap-
proved by the University of British Columbia Research
Table 1 Clinical features of reported patients with Desmosterolosis
Feature Present family Previously reported cases of desmosterolosis Frequency
(n = 9)Patient 1 Patient 2 Patient 31 Patients 4-72 Patient 83 Patient 94






c.[1412A>C] + [881A > C;918G>C]
p.[Y471S] + [N294T; K306N]
Protein domain FAD-binding domain FAD-binding domain FAD-binding domain FAD-binding domain + C
terminal cytoplasmic
domain
C terminal cytoplasmic domain
Ancestry Middle Eastern European Israeli Bedouin European
Failure to thrive 1 1 1 4/4 1 n.a. 8/8
Short stature 1 1 1 n.a. n.a. 0 3/4
Microcephaly 0 0 1 4/4 0 0 5/9
Macrocephaly 0 0 0 0/4 1 1 2/9
Microretrognatia 1 0 1 4/4 1 1 8/9
Cleft palate 1 0 1 0 0 1 3/9
Facial features Dolicocephaly; bitemporal














nose; low set ears;
cleft palate
ID/DD 1 1 1 4/4 1 n.a. 8/8
Spasticity 1 1 1 4/4 n.a. n.a. 7/7
Distal
arthrogryposis
1 1 1 4/4 1 0 8/9
Large joint
contractures
0 1 (talipes) 1 (talipes) n.a. 1 1 4/5
Shortening of
the limbs
0 0 0 n.a. 1 1 2/5
ACC (partial/full) 1 1 1 4/4 1 1 9/9
Ventriculomegaly 1 1 0 4/4 1 1 8/9
Cerebral WM
atrophy
1 1 1 4/4 1 n.a. 8/8
Cerebellar WM
atrophy
1 1 n.a. 2/2 n.a. n.a. 4/4
Nystagmus
/strabismus
1 1 0 3/4 0 n.a. 5/8




















Table 1 Clinical features of reported patients with Desmosterolosis (Continued)







hypoplasia; death at 1 h










References: 1: Waterham et al. [2], Andersson et al. [8]; 2: Zolotushko et al. [7]; 3: Schaaf et al. [9]; 4: FitzPatrick et al. [1], Waterham et al. [2].
Abbreviations: ACC agenesis of the corpus callosum, DD developmental delay, ID intellectual disability, n.a. not available, PF palpebral fissures, PDA patent ductus arteriosus, SNHL sensorineural hearing loss, WM white
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Additional files
Additional file 1: Supplementary methods. Exome sequencing and
Gas chromatography-mass spectroscopy analysis.
Additional file 2: Figure S1. Molecular confirmation of Desmosterolosis
through exome sequencing and Sanger sequencing. NextGene
(Softgenetics, Pennsylvania) view of the exome sequencing reads for one
affected child (A) and dideoxy nucleotide sequencing validation (B) for
the mother, father, and both affected children. The mother and father
were heterozygous for NM_014762.3:c.571G > A (p.E191K) mutation. The
propositae have the mutation in homozygosity.
Abbreviations
bp: base pair; CNS: Central nervous system; IQ: Intelligence quotient;
DHCR24: 3-β-hydroxysterol Δ-24-reductase; EBP: Emopamil binding protein;
FISH: Fluorescence in situ hybridization; ID: Intellectual disability;
MRI: Magnetic resonance imaging; 7-DHC: 7-dehidrocholesterol; PE: Paired-end.
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